109 related articles for article (PubMed ID: 11568144)
1. Enhanced in vivo and in vitro contractile responses to beta(2)-adrenergic receptor stimulation in dogs susceptible to lethal arrhythmias.
Houle MS; Altschuld RA; Billman GE
J Appl Physiol (1985); 2001 Oct; 91(4):1627-37. PubMed ID: 11568144
[TBL] [Abstract][Full Text] [Related]
2. Beta2-adrenergic receptor antagonists protect against ventricular fibrillation: in vivo and in vitro evidence for enhanced sensitivity to beta2-adrenergic stimulation in animals susceptible to sudden death.
Billman GE; Castillo LC; Hensley J; Hohl CM; Altschuld RA
Circulation; 1997 Sep; 96(6):1914-22. PubMed ID: 9323081
[TBL] [Abstract][Full Text] [Related]
3. Endurance exercise training attenuates cardiac beta2-adrenoceptor responsiveness and prevents ventricular fibrillation in animals susceptible to sudden death.
Billman GE; Kukielka M; Kelley R; Moustafa-Bayoumi M; Altschuld RA
Am J Physiol Heart Circ Physiol; 2006 Jun; 290(6):H2590-9. PubMed ID: 16387787
[TBL] [Abstract][Full Text] [Related]
4. beta(1) and beta(2)-adrenergic receptor subtype effects in German shepherd dogs with inherited lethal ventricular arrhythmias.
Sosunov EA; Gainullin RZ; Moise NS; Steinberg SF; Danilo P; Rosen MR
Cardiovasc Res; 2000 Nov; 48(2):211-9. PubMed ID: 11054468
[TBL] [Abstract][Full Text] [Related]
5. Greater glycogen utilization during 1- than 2-adrenergic receptor stimulation in the isolated perfused rat heart.
McConville P; Lakatta EG; Spencer RG
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1828-35. PubMed ID: 17911346
[TBL] [Abstract][Full Text] [Related]
6. Autonomic response to coronary occlusion in animals susceptible to ventricular fibrillation.
Collins MN; Billman GE
Am J Physiol; 1989 Dec; 257(6 Pt 2):H1886-94. PubMed ID: 2603974
[TBL] [Abstract][Full Text] [Related]
7. Murine ventricular L-type Ca(2+) current is enhanced by zinterol via beta(1)-adrenoceptors, and is reduced in TG4 mice overexpressing the human beta(2)-adrenoceptor.
Heubach JF; Graf EM; Molenaar P; Jäger A; Schröder F; Herzig S; Harding SE; Ravens U
Br J Pharmacol; 2001 May; 133(1):73-82. PubMed ID: 11325796
[TBL] [Abstract][Full Text] [Related]
8. Cardioprotective and antiarrhythmic effects of beta-blockers, propranolol, bisoprolol, and nipradilol in a canine model of regional ischemia.
Ogawa T; Hieda N; Sugiyama S; Ito T; Satake T; Ozawa T
Heart Vessels; 1989; 5(1):10-6. PubMed ID: 2573596
[TBL] [Abstract][Full Text] [Related]
9. β2-adrenoceptor transfection enhances contractile reserve of isolated rat ventricular myocytes exposed to chronic isoprenaline stimulation by improving β1-adrenoceptor responsiveness.
Jiang X; Xu C; Wang Y; Gao L; Yan C; Li D; Sun H
J Recept Signal Transduct Res; 2012 Feb; 32(1):36-41. PubMed ID: 22216755
[TBL] [Abstract][Full Text] [Related]
10. Role of force--frequency relation during AV-block, sinus node block and beta-adrenoceptor block in conscious animals.
De Pauw M; Vilaine JP; Heyndrickx GR
Basic Res Cardiol; 2004 Sep; 99(5):360-71. PubMed ID: 15338245
[TBL] [Abstract][Full Text] [Related]
11. Antiarrhythmic efficacy of combined I(Ks) and beta-adrenergic receptor blockade.
Lynch JJ; Salata JJ; Wallace AA; Stump GL; Gilberto DB; Jahansouz H; Liverton NJ; Selnick HG; Claremon DA
J Pharmacol Exp Ther; 2002 Jul; 302(1):283-9. PubMed ID: 12065728
[TBL] [Abstract][Full Text] [Related]
12. Regulation of cyclic adenosine monophosphate release by selective β2-adrenergic receptor stimulation in human terminal failing myocardium before and after ventricular assist device support.
Kassner A; Toischer K; Bohms B; Kolkhof P; Abraham G; Hasenfuβ G; Morshuis M; Schulte Eistrup S; El-Banayosy A; Gummert J; Milting H
J Heart Lung Transplant; 2012 Oct; 31(10):1127-35. PubMed ID: 22975104
[TBL] [Abstract][Full Text] [Related]
13. Antifibrillatory efficacy of ersentilide, a novel beta-adrenergic and Ikr blocker, in conscious dogs with a healed myocardial infarction.
Adamson PB; Vanoli E; Hull SS; Foreman RD; Schwartz PJ
Cardiovasc Res; 1998 Oct; 40(1):56-63. PubMed ID: 9876317
[TBL] [Abstract][Full Text] [Related]
14. The antiarrhythmic and cardiovascular properties of 1-dimethyl isopropylamino-3-(2-phenylphenoxy)-propan-2-ol chloride, UM-424.
Kniffen FJ; Winokur S; Counsell RE; Lucchesi BR
J Pharmacol Exp Ther; 1976 Feb; 196(2):420-32. PubMed ID: 3643
[TBL] [Abstract][Full Text] [Related]
15. Early developmental 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure decreases chick embryo heart chronotropic response to isoproterenol but not to agents affecting signals downstream of the beta-adrenergic receptor.
Sommer RJ; Hume AJ; Ciak JM; Vannostrand JJ; Friggens M; Walker MK
Toxicol Sci; 2005 Feb; 83(2):363-71. PubMed ID: 15564318
[TBL] [Abstract][Full Text] [Related]
16. Influence of beta 2-adrenoceptor stimulation and blockade on cardiac electrophysiologic properties and serum potassium concentration in the anesthetized dog.
Hohnloser SH; Verrier RL; Lown B
Am Heart J; 1987 May; 113(5):1066-70. PubMed ID: 2883866
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of beta- but not alpha 1-mediated adrenergic responses in isolated hearts and cardiomyocytes by nitric oxide and 8-bromo cyclic GMP.
Ebihara Y; Karmazyn M
Cardiovasc Res; 1996 Sep; 32(3):622-9. PubMed ID: 8881523
[TBL] [Abstract][Full Text] [Related]
18. Identification and functional role of beta-adrenergic receptor subtypes in primate and rodent: in vivo versus isolated myocytes.
Cui Y; Shen YT; Kalthof B; Iwase M; Sato N; Uechi M; Vatner SF; Vatner DE
J Mol Cell Cardiol; 1996 Jun; 28(6):1307-17. PubMed ID: 8782072
[TBL] [Abstract][Full Text] [Related]
19. Low-frequency component of the heart rate variability spectrum: a poor marker of sympathetic activity.
Houle MS; Billman GE
Am J Physiol; 1999 Jan; 276(1):H215-23. PubMed ID: 9887035
[TBL] [Abstract][Full Text] [Related]
20. Anti-arrhythmic action of nadolol, a beta-adrenergic receptor blocking agent.
Evans DB; Peschka MT; Lee RJ; Laffan RJ
Eur J Pharmacol; 1976 Jan; 35(1):17-27. PubMed ID: 3420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
